IL2 and neoplasm: Several cytokines, among others including IL-2, IL-12, IL-15, IL-21, GM-CSF and INF-α, have demonstrated efficacy in preclinical models of murine cancer [79]; however, cytokines have shown limitations, such as their short half-life and narrow therapeutic framework, with low anti-tumour efficacy in their use as monotherapy agent.